Turku University Hospital — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Turku University Hospital appears in 96 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials96

Recruiting shown10

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Usability Study of Gestational and Postpartum Weight Management ProgramNCT07272824 · lead sponsor · 2025-12-09

Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid HemorrhageNCT04696523 · lead sponsor · 2025-04-22

Virtual Pulmonary Rehabilitation Program for COPD Patients; a Pilot StudyNCT06915740 · lead sponsor · 2025-03-31

Study on Recurrent Breast Cancer and Repeated Radiation TherapyNCT06704659 · lead sponsor · 2024-12-01

Noninvasive Evaluation of Fetal Hyperinsulinemia With Ultrasound RadiomicsNCT06343974 · lead sponsor · 2024-10-11

Resilience to Antibiotic-induced Obesogenic Microbiota: Discovering Mechanism of Microbiota ModulationNCT06974994 · lead sponsor · 2024-05-08

Total-body Glucose Utilization in ObesityNCT06739473 · lead sponsor · 2023-01-25

Prostate Medication, Metabolism and Gut MicrobiotaNCT06001619 · lead sponsor · 2022-12-01

99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate CancerNCT06219746 · lead sponsor · 2022-06-01

bpMRI and Risk Based Shared Clinical Decision Making in Prostate Cancer DiagnosisNCT04287088 · lead sponsor · 2020-02-17

Exploring Pathology Related to Slowly Expanding Lesions Using Advanced ImagingNCT06460077 · lead sponsor · 2024-10-03

ENROLLING_BY_INVITATION

Food Intake, Endocrine Factors and Brown FatNCT06285461 · lead sponsor · 2024-02-20

ACTIVE_NOT_RECRUITING

Brain Insulin Resistance in Mild Cognitive ImpairmentNCT06116188 · lead sponsor · 2023-10-12

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9NCT05212103 · lead sponsor · 2023-09-01

ENROLLING_BY_INVITATION

Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate CancerNCT05917860 · lead sponsor · 2023-07-18

ACTIVE_NOT_RECRUITING

Weight Load PET (WELPET)NCT05443620 · lead sponsor · 2022-08-01

Cold Acclimation as a Modulator of Brown Adipose Tissue Function in Adults With ObesityNCT05468151 · lead sponsor · 2022-07-25

ACTIVE_NOT_RECRUITING

Prostate Metabolism, Cancer Risk and Gut MicrobiotaNCT06116851 · lead sponsor · 2022-06-01

Open-Label Prospective Study Comparing Long-Term Outcome With or Without HFNC in Patients With Stable Hypercapnic COPDNCT04840706 · lead sponsor · 2022-04-21

Interaction of Sleep, Diurnal Eating Pattern, Gut Microbiota, and ObesityNCT04850391 · lead sponsor · 2021-10-01

Exercise and Tumor Blood Flow in Lymphoma And Breast Cancer Patients (EXETUMOR 3)NCT04990856 · lead sponsor · 2021-08-10

Does Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis PatientsNCT04625049 · lead sponsor · 2021-04-01

ENROLLING_BY_INVITATION

A Repeatability Study of Fatty Acid Uptake Using PET/MR Imaging in Patients With T2DM and Non-diabetic Control SubjectsNCT05132335 · lead sponsor · 2021-03-29

Exercise and Tumor Blood Flow in Breast Cancer PatientsNCT04416087 · lead sponsor · 2020-09-07

Liraglutide in the Prevention of Type 2 Diabetes After Gestational DiabetesNCT04324229 · lead sponsor · 2020-02-07

ACTIVE_NOT_RECRUITING

Effect of Cladribine Treatment on Microglial Activation in the CNSNCT04239820 · lead sponsor · 2020-01-10

ACTIVE_NOT_RECRUITING

Processing of Music in Alzheimer PatientsNCT04132193 · lead sponsor · 2019-10-01

The Effect of ADT on PSMA Expression in Metastatic Prostate CancerNCT03876912 · lead sponsor · 2019-03-01

Multimodal Imaging of MS Reveals the Smoldering InflammationNCT04126772 · lead sponsor · 2019-02-27

ACTIVE_NOT_RECRUITING

Effects of Morbid Obesity and Bariatric Surgery on Brain Inflammation, and Activation of Central Reward SystemNCT04343469 · lead sponsor · 2019-02-11

Effects of Morbid Obesity and Bariatric Surgery on Brain Inflammation, Insulin Resistance and Central Reward SystemNCT05080205 · lead sponsor · 2019-02-11

Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary SarcoidosisNCT03755245 · lead sponsor · 2018-11-23

ENROLLING_BY_INVITATION

Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate CancerNCT03814252 · lead sponsor · 2018-10-30

ACTIVE_NOT_RECRUITING

Novel Imaging in Staging of Primary Prostate CancerNCT03537391 · lead sponsor · 2018-03-01

Postcardiotomy Venoarterial Extracorporeal Membrane OxygenationNCT03508505 · lead sponsor · 2018-01-01

Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of ProgressionNCT03368677 · lead sponsor · 2017-12-01

ACTIVE_NOT_RECRUITING

Assessing Neurovisual Function in Patients With Cognitive ImpairmentNCT03333096 · lead sponsor · 2017-12-01

The Effect of ADT on PSMA-PET.NCT03313726 · lead sponsor · 2017-09-20

MRI Guided Transurethral HIFU for Various Prostate DiseasesNCT03350529 · lead sponsor · 2017-07-24

Neuromolecular Risk Factors for Obesity (PROSPECT)NCT03106688 · lead sponsor · 2017-04-04

Predicting Exacerbation of COPD With Wireless TelemonitoringNCT02791451 · lead sponsor · 2016-10-01

Secretin Activates Human Brown Fat and Induces Satiation.NCT03290846 · lead sponsor · 2016-08-02

Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and BiomarkersNCT02844829 · lead sponsor · 2016-07-01

Role of Microglia in the Pathogenesis of Progressive Multiple SclerosisNCT03134716 · lead sponsor · 2016-04-01

ACTIVE_NOT_RECRUITING

Adenosine and A2A Receptors in Human Brown Adipose TissueNCT03327168 · lead sponsor · 2015-11-01

Glucose-stimulated Pancreatic Islet and Intestinal Blood Flow in Healthy Subjects and in Type 1 DiabetesNCT02547337 · lead sponsor · 2015-09-10

Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer AggressivenessNCT02545881 · lead sponsor · 2015-07-01

Late Metabolic Effects of Metformin Therapy in Gestational DiabetesNCT02417090 · lead sponsor · 2015-05-01

MRI and Biomarkers in Prostate CancerNCT02241122 · lead sponsor · 2015-04-01

Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle GlaucomaNCT02379208 · lead sponsor · 2015-04-01

Transcranial Direct Current Stimulation (tDCS) as an add-on Therapy for Treatment of Major Depressive Disorder. (DEPTDCS2014)NCT02521883 · lead sponsor · 2015-03-01

Prostate Magnetic Resonance Imaging in Patient With Previous Negative BiopsiesNCT02388126 · lead sponsor · 2015-03-01

Rotating Frame Relaxation Imaging in Patients With Multiple SclerosisNCT02403570 · lead sponsor · 2015-02-01

Non-motor Symptoms and Brain Dopamine Transporter BindingNCT02650843 · lead sponsor · 2015-01-01

ACTIVE_NOT_RECRUITING

CB1 Receptors in Human Brown Adipose TissueNCT02941172 · lead sponsor · 2015-01-01

Longitudinal Follow-up of Brown Adipose Tissue Function and StructureNCT01985503 · lead sponsor · 2015-01-01

Supportive Treatment of Severe Heart Failure by Renal DenervationNCT02638324 · lead sponsor · 2014-12-01

Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRINCT02002455 · lead sponsor · 2013-12-01

Nutrition and Pregnancy Intervention StudyNCT01922791 · lead sponsor · 2013-10-01

Sphingosine-1 Phosphate -Receptor Targeting and Microglial ActivationNCT02139696 · lead sponsor · 2013-09-01

Drugs studied in this sponsor's trials

11 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Turku University Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

metformin3

adenosine1

anakinra1

degarelix1

docetaxel1

duloxetine1

liraglutide 6 MG/ML [Victoza]1

prednisolone1

metformin RxCUI 6809 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials adenosine RxCUI 296 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial anakinra RxCUI 72435 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial degarelix RxCUI 475230 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial docetaxel RxCUI 72962 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial duloxetine RxCUI 72625 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial liraglutide 6 MG/ML [Victoza] RxCUI 897124 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial prednisolone RxCUI 8638 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial pregabalin RxCUI 187832 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial rosiglitazone RxCUI 84108 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial tramadol RxCUI 10689 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor73

collaborator23

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.